Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells

Journal of Controlled Release

Volumn 133, Issue 3, 2009, Pages 185-190

  Kishimoto, Satoko ^a,b   Nakamura, Shingo ^a   Nakamura, Shin ichiro ^a   Hattori, Hidemi ^a   Oonuma, Fumie ^a   Kanatani, Yasuhiro ^a   Tanaka, Yoshihiro ^a   Harada, Yasuji ^b   Tagawa, Masahiro ^b   Maehara, Tadaaki ^a   Ishihara, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

CD 34 positive hematopoietic progenitor cells (CD 34 (+) HCs); Cell proliferation; Controlled drug release; Cytokine; Low molecular weight heparin protamine microparticles (LH P MPs)

Indexed keywords

CELL GROWTH; CELL PROLIFERATION; CELLS; CYTOLOGY; DATA STORAGE EQUIPMENT; FLOW CYTOMETRY; MOLECULAR WEIGHT; PLASTIC COATINGS; TISSUE CULTURE;

CD 34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS (CD 34 (+) HCS); CONTROLLED DRUG RELEASE; CULTURE METHODS; CYTOKINE; CYTOMETRY; GROWTH MEDIUM; LOW MOLECULAR WEIGHT HEPARIN/PROTAMINE MICROPARTICLES (LH/P MPS); MICRO PARTICLES; PLASTIC SURFACES; STEM CELL FACTOR (SCF); TISSUE CULTURE PLATES;

CELL CULTURE;

CD34 ANTIGEN; CYTOKINE; FLT3 LIGAND; LOW MOLECULAR WEIGHT HEPARIN; PROTAMINE; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; CD34 SELECTION; CELL GROWTH; CELL PROLIFERATION; COATED PARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; MEMBRANE MICROPARTICLE; MOLECULAR STABILITY; PRIORITY JOURNAL; STEM CELL EXPANSION; SURFACE PROPERTY;

ANTIGENS, CD34; BINDING, COMPETITIVE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CULTURE MEDIA; CYTOKINES; DALTEPARIN; DELAYED-ACTION PREPARATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HEMATOPOIETIC STEM CELLS; HEPARIN; HUMANS; KINETICS; MEMBRANE PROTEINS; MICROSPHERES; MOLECULAR WEIGHT; PARTICLE SIZE; PROTAMINES; STEM CELL FACTOR; THROMBOPOIETIN;

EID: 58549094495     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.10.005     Document Type: Article

References (24)

1. Parmar K., Mauch P., Vergilio J.A., Sackstein R., and Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 5431-5436
2. Hung S.C., Chen N.J., Hsieh S.L., Li H., Ma H.L., and Lo W.H. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 20 (2002) 249-258
3. Hofmeister C.C., Zhang J., Knight K.L., Le P., and Stiff P.J. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant. 39 (2007) 11-23
4. Wilson A., and Trump A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6 (2006) 93-106
5. Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
6. Zubler R.H. Ex vivo expansion of hematopoietic stem cells and gene therapy development. Swiss Med. Wkly. 136 (2006) 795-799
7. Gupta P., Oegema T.R., Brazil J.J., Dudek A.Z., Slungaard A., and Verfaillie C.M. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 92 (1998) 4641-4651
8. Alvarez-Silva M., and Borojevic R. GM-CSF and IL-3 activities in schistosomal liver granulomas are controlled by stroma-associated heparan sulfate proteoglycans. J. Leukoc. Biol. 59 (1996) 435-441
9. Roberts R., Gallagher J., Spooncer E., Allen T.D., Bloomfield F., and Dexter T.M. Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332 (1988) 376-378
10. Gordon M.Y., Riley G.P., Watt S.M., and Greaves M.F. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326 (1987) 403-405
11. Drayer A.L., Olthof S.G., and Vellenga E. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors. Stem Cells 24 (2006) 105-114
12. Schepers H., Wierenga A.T., Gasliga D.V., Eggen B.J., Vellenga E., and Schuringa J.J. Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. Blood 110 (2007) 1317-1325
13. Ishihara M., and Ono K. Structure and function of heparin and heparan sulfate: heparinoid library and modification of FGF-activities. Trend Glycosci. Glycotech. 10 (1998) 223-233
14. Ishihara M. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trend Glycosci. Glycotech. 5 (1993) 343-354
15. Salmivirta M., Lidholt K., and Lindahl U. Heparan sulfate: a piece of information. FASEB. J. 10 (1996) 1270-1279
16. Lindahl U., Lidholt K., Spillmann D., and Kjellen L. More to "heparin" than anticoagulation. Thromb. Res. 75 (1994) 1-32
17. Hirsh J., Warkentin T.E., Raschke R., Granger C., Ohman E.M., and Dalen J.E. Heparin and low-molecular-weight heparin, mechanisms of action, phormacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114 (1998) 489S-510S
18. Wolzt M., Wetermann A., Nieszpaur-Los M., Schneider B., Fassolt A., Lechner K., Eichler H.G., and Kyrle P.A. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (FragminR) at the site of activation of the coagulation system in man. Thromb. Haemost. 73 (1995) 439-443
19. Pan M., Lezo J.S., Medina A., Romero M., Hernandez E., Segura J., Melian F., Wanguemert F., Landin M., Benitez F., Amat M., Velasco F., and Torres A. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am. J. Cardiol. 80 (1997) 1336-1338
20. S. Nakamura, Y. Kanatani, S. Kishimoto, M. Nambu, C. Ohno, H. Hattori, B. Takase, Y. Tanaka, T. Kiyosawa, T. Maehara, M. Ishihara, Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization, J. Biomed. Mater. Res. (A) (in press).
21. Nakamura S., Nambu M., Kishimoto S., Ishizuka T., Hattori H., Kanatani Y., Takase B., Aoki H., Kiyosawa T., Maehara T., and Ishihara M. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex hydrogel on in vitro and in vivo vascularization. J. Biomed. Mater. Res. (A) 85A (2008) 619-627
22. Fujita M., Ishihara M., Shimizu M., Obara K., Ishizuka T., Saito Y., Yura H., Morimoto Y., Takase B., Matsui T., Kikuchi M., and Maehara T. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel. Biomaterials 25 (2004) 699-706
23. Okamoto T., Takagi M., Soma T., Ogawa H., Kawakami M., Mukubo M., Kubo K., Sato R., Toma K., and Yoshida T. Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics. J. Artif. Organs. 7 (2004) 194-202
24. Cousin B., Andre M., Arnaud E., Penicaud L., and Casteilla L. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem. Biophys. Res. Comm. 301 (2003) 1016-1022